A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Gabapentin Extended Release (G-ER) Tablets in the Treatment of Patients With Postherpetic Neuralgia.

Trial Profile

A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Gabapentin Extended Release (G-ER) Tablets in the Treatment of Patients With Postherpetic Neuralgia.

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Sep 2015

At a glance

  • Drugs Gabapentin (Primary)
  • Indications Neuropathic pain; Postherpetic neuralgia
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Sep 2015 Results of pooled data analysis from patients, enrolled in two phase 3 randomised, double-blind, placebo-controlled studies (81-0045 and 81-0062) and one phase 4 study (81-0067) published in the Journal of Pain.
    • 03 May 2014 Results from a pooled analysis presented at the 33rd Annual Scientific Meeting of the American Pain Society.
    • 23 Jul 2012 Results were published in the Clinical Journal of Pain (online edition), according to a Depomed media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top